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Abstract
Human cell lines are often used to investigate cellular pathways relevant for physiological or
pathological processes or to evaluate cell toxicity or protection induced by different com-
pounds, including potential drugs. In this study, we analyzed and compared the differentiat-
ing activities of three agents (retinoic acid, staurosporine and 12-O-tetradecanoylphorbol-
13-acetate) on the human neuroblastoma SH-SY5Y and BE(2)-M17 cell lines; the first cell
line is largely used in the field of neuroscience, while the second is still poorly characterized.
After evaluating their effects in terms of cell proliferation and morphology, we investigated
their catecholaminergic properties by assessing the expression profiles of the major genes
involved in catecholamine synthesis and storage and the cellular concentrations of the neu-
rotransmitters dopamine and noradrenaline. Our results demonstrate that the two cell lines
possess similar abilities to differentiate and acquire a neuron-like morphology. The most
evident effects in SH-SY5Y cells were observed in the presence of staurosporine, while in
BE(2)-M17 cells, retinoic acid induced the strongest effects. Undifferentiated SH-SY5Y and
BE(2)-M17 cells are characterized by the production of both NA and DA, but their levels are
considerably higher in BE(2)-M17 cells. Moreover, the NAergic phenotype appears to be
more pronounced in SH-SY5Y cells, while BE(2)-M17 cells have a more prominent DAergic
phenotype. Finally, the catecholamine concentration strongly increases upon differentiation
induced by staurosporine in both cell lines. In conclusion, in this work the catecholaminergic
phenotype of the human BE(2)-M17 cell line upon differentiation was characterized for the
first time. Our data suggest that SH-SY5Y and BE(2)-M17 represent two alternative cell
models for the neuroscience field.
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Introduction
In the vertebrate central nervous system, catecholaminergic (CAergic) neurons constitute
anatomically discrete groups of cells that synthesize and release the neurotransmitters dopa-
mine (DA) and noradrenaline (NA). DAergic neurons, which originate in the ventral tegmen-
tal area, the substantia nigra and the hypothalamus, are involved in motor control, the control
of emotional balance, reward-associated behavior, attention, and memory and the secretion of
hormones such as prolactin [1] The majority of NA neurons are concentrated in the locus coe-
ruleus and contribute to the regulation of arousal, sleep–wake patterns, sensory perception and
emotional status [2, 3]. Considering the numerous functions attributed to the activity of CAer-
gic neurons, it is not surprising that this class of cells is associated with multiple neurodegener-
ative, psychiatric, and endocrine disorders. For example, the selective degeneration of DAergic
neurons in the substantia nigra is associated with the trembling and muscular rigidity that are
symptomatic of Parkinson’s disease. A malfunction in the mesocortical and mesolimbic DAer-
gic pathways is linked to schizophrenia and the attention deficit, addiction, and hyperactivity
disorders. Dysregulation of the NAergic system may result in deficits in a variety of cognitive
and affective processes and is related to depression and sleep disorders.
A number of cellular models have been described to gain insight into the molecular path-
ways that are dysfunctional in CAergic-related disorders and to investigate potential therapeu-
tic agents. Among them, human neuroblastoma cell lines have been used as in vitromodels for
the study of the mechanisms of action and neurotoxicity of compounds on the nervous system
[4]. Furthermore, neuroblastoma cell lines can be differentiated with chemicals or growth
factors supplied to the cultured medium. Differentiation arrests cell division and induces mor-
phological changes that are characteristic of neurons, including the extension of neurites.
Importantly, these cells have been reported to release neurotransmitters under depolarizing
conditions [5–9].
The human neuroblastoma SH-SY5Y cell line (ATCC CRL-2266) has been largely used in
the field of neuroscience, particularly to generate different Parkinson’s disease cell models [10–
12]. These cells, which were subcloned from the SK-N-SH cell line, are of neuronal origin,
express tyrosine hydroxylase (TH) and exhibit moderate levels of dopamine-β-hydroxylase
(DßH) activity, which is specific for NAergic neurons [13]. A variety of agents, including reti-
noic acid (RA) [12, 14], phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) [15, 16],
brain-derived neurotrophic factor [17], dibutyryl cyclic AMP [18] and staurosporine [19], have
been used to induce differentiation. In contrast to SH-SY5Y cells, much less is known about
the BE(2)-M17 cell line (ATCC CRL-2267). These cells were cloned from the SK-N-BE(2) neu-
roblastoma cell line isolated from a 2-year-old male. Although the first biochemical characteri-
zation of these cells dates back to the 1980s [20, 21], their use has been limited. Differentiation
with RA has been shown to induce morphological and metabolic changes that confer neuro-
nal-like features [7, 22]. However, little is known about the CAergic pathway of BE(2)-M17
cells in the undifferentiated and differentiated states.
In this study, we compared the differentiating activities of three agents (RA, staurosporine
and TPA) on SH-SY5Y and BE(2)-M17 cells; these agents were selected on the basis of their
previous characterization in the SH-SY5Y cell line and ease of manipulation. Specifically, we
analyzed a number of morphological properties, including the expression of the neuron-spe-
cific proteins β-tubulin III and neurofilament. Then, we focused on the CAergic pathway by
evaluating the expression profiles of the major genes involved in CA synthesis and storage and
the presence of DA and NA upon differentiation. Our results emphasize that the two cell lines
tested possess similar abilities to differentiate and acquire neuron-like morphology. The most
evident effects in the SH-SY5Y cells were observed in the presence of staurosporine, while RA
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induced the strongest effects in the BE(2)-M17 cells. There were some relevant differences in
the CAergic pathway between the two cell lines. Undifferentiated SH-SY5Y cells produce both
NA and DA, but the NAergic phenotype appears to be more pronounced. The CA concentra-
tion is strongly increased after staurosporine-induced differentiation and the cells become
mostly NAergic. Undifferentiated BE(2)-M17 cells produce both NA and DA, but their
amounts are significantly higher compared with those produced by SH-SY5Y cells and their
phenotype is more DAergic. The CA concentration in these cells is also strongly increased
upon differentiation with staurosporine.
Materials and Methods
Reagents
Tissue culture reagents were purchased from Gibco/Life Technologies. Chemicals were
obtained from Sigma-Aldrich. Stock solutions of RA were prepared by dissolving the powder
in DMSO, and TPA and staurosporine were dissolved in 100% ethanol. In all of the experi-
ments, the final concentration of ethanol never exceeded 0.1% and had no detectable effect on
cell growth or differentiation. The SH-SY5Y and BE(2)-M17 cell lines were purchased from the
Cell Factory-IST Genova and LGC standards, respectively.
Cell culture and differentiation
Undifferentiated human neuroblastoma SH-SY5Y and BE(2)-M17 cells were maintained in a
1:1 mixture of Ham's F12 and Dulbecco’s Modified Eagle’s Medium supplemented with 10%
fetal bovine serum and grown in the presence of 5% CO2 in a humidified incubator at 37°C.
The cell medium was replaced every 3 days, and the cells were sub-cultured once confluence
was reached. In all of the experiments, the cells were used at early passages (P1-5 after pur-
chase). Differences in morphology between proliferative and differentiated cells were evaluated
by phase contrast light microscopy (Motic AE2000)
For cell proliferation analysis, 1×105 cells were seeded into 25 cm2 flasks. Twenty-four
hours after seeding, differentiation was induced by the addition of TPA, RA or staurosporine at
concentrations of 15 nM, 10 μM or 10 nM for SH-SY5Y cells and 30 nM, 5 μM or 8 nM for BE
(2)-M17 cells, respectively. Fresh media containing the specified inducing agent was provided
every 2 days. To determine the rate of cell growth, cells were harvested after a 0.05% trypsin
treatment and quantified using a hemocytometer. Briefly, approximately 5–10 μl of the cell sus-
pension was added into the Bürker chamber. Cells were counted in four large 1 mm2 squares
under an inverted phase contrast microscope using a 10X magnification. Then, the average
number of cells per square was determined. The total number of cells overlying a 1 mm2 square
was in the range of 30–150.
Immunocytochemistry and immunofluorescence
Cells were plated at a density of 2×104 cells/coverslip in 2 ml of medium on 15 mm glass cover-
slips pre-coated with poly-D-lysine. After 7 days of differentiation, the cells were fixed for 30
min at room temperature with 4% paraformaldehyde in a phosphate buffered saline (PBS)
solution (pH 7.4), rinsed three times with PBS, permeabilized with 0.1% Triton X-100 in PBS
for 30 min at room temperature and incubated in blocking solution (5% fetal bovine serum in
PBS) for 30 min at room temperature. The cells were incubated for 1 hour at room temperature
with primary antibodies diluted in blocking solution. The primary antibodies used in this study
included mouse anti-neurofilament (1:1000, Covance) and mouse anti-neuron specific β-III
tubulin (1:200, Sigma). After 3 washes in PBS, the cells were subsequently incubated with
Catecholaminergic Phenotype in Neuroblastoma Cell Lines
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secondary anti-mouse antibodies conjugated with Alexa Fluor-488 and -568 (Life technologies)
at a 1:200 dilution for 1 hour at room temperature. Nuclei were counterstained using 0.16 μM
Hoechst 33258 (Gibco/Life Technologies) for 5 min, and after extensive washing in PBS the
coverslips were mounted with ProLong Gold Antifade (Life Technologies). Images were
acquired using a Leica DM5000 epifluorescence microscope.
Neuritic outgrowth
To measure neuritic outgrowth after differentiation, SH-SY5Y and BE(2)-M17 cells were
seeded onto coverslips pre-coated with poly-D-lysine. After 24 hours, the cells were transfected
with a vector containing the coding sequence for a cytosolic green fluorescent protein whose
expression allowed the neurite length to be tracked at the single cell level using a fluorescence
microscope. The day after transfection, differentiation was induced as described above. After 7
days of treatment, the samples were fixed; approximately 30 cells were analyzed for each condi-
tion. Images were acquired using a Leica 5000B epifluorescence microscope with a magnifica-
tion of 20X. Neurite length was assessed using ImageJ software.
mRNA expression analysis using semi-quantitative and quantitative
real-time PCR
The determination of gene expression levels was performed using quantitative real-time PCR
(qRT-PCR). Total RNA was extracted from undifferentiated or differentiated cells using TRI-
zol according to the manufacturer’s instructions (Gibco/Life Technologies). Reverse transcrip-
tion was performed using the ImProm II Reverse Transcription System (Promega), and cDNA
was obtained for the qRT-PCR reactions. Semi-quantitative PCR was performed with the
GoTaq DNA Polymerase (Promega) using the following conditions for amplification: a single
denaturation step at 95°C for 5 min, followed by 30 cycles of 30 s of denaturation at 95°C, 30 s
of annealing at 60°C and 1 min of extension at 72°C, and a final extension step at 72°C for 10
min. Amplified DNA was subsequently analyzed through 2% agarose gel electrophoresis, and
the images were acquired using the Gel Doc XR System (Bio-Rad). For quantitative analysis,
qRT-PCR assays were performed in 96-well optical plates with a 7500 real-time PCR system
(Applied Biosystems) using the following parameters: 95°C for 10 min, 38 cycles of 20 s at
95°C and 60 s at 60°C, followed by 2 cycles of 15 s at 95°C and 60 s at 60°C. cDNA was ampli-
fied using the Power SYBR Green Master Mix (Applied Biosystems) containing 0.2 μM of the
primers. The primer sequences (forward and reverse) and the expected lengths of the amplified
products are listed in Table 1. The expression of individual target genes was calculated using
the ΔΔCt-method [23]. Sample Ct−values were normalized by Ct−values of the housekeeping
genes. In the SH-SY5Y cells, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was the ref-
erence gene used for aromatic L-amino acid decarboxylase (AADC) and dopamine-β-hydroxy-
lase (DβH) quantification, while RNA polymerase II (RPII) was used for tyrosine hydroxylase
(TH) and vesicular monoamine transporter 2 (VMAT2). In the BE(2)-M17 cells, GAPDH was
the internal control gene used for AADC quantification, while RNA polymerase II was used for
TH, VMAT2 and DβH. These two housekeeping genes were expressed at the same levels as the
target genes. These results were further normalized using undifferentiated cells. For each con-
dition tested, three technical replicates were performed and the average value was determined.
Quantification of catecholamine levels
Undifferentiated and TPA-, RA- or staurosporine-treated cells were harvested, washed with
PBS, and mixed with ice-chilled 0.2 M perchloric acid containing 5 mM EDTA and 5 mM
sodium bisulfate (250 μl of cell lysis solution was used for every 107 cells). Lysates were
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centrifuged at 7000 x g for 20 min at 4°C, and the supernatants were collected and stored
immediately at -80°C prior to analysis. High-performance liquid chromatography (HPLC)
(Agilent 1100 Series) coupled with an ESA Coulochem II electrochemical detector was used to
measure the NA and DA concentrations. Separations were achieved on a 150 × 4.6 mmWaters
C18 column. The mobile phase consisted of 75 mM NaH2PO4, 1.7 mM 1-octanesulfonic acid,
25 μM EDTA and 10% (v/v) acetonitrile adjusted to pH 3 with phosphoric acid. The column
was maintained at room temperature, and the flow rate was 0.6 ml/min. An analytical cell ESA
5011A was used with the electrochemical potentials set at -150 mV and +220 mV. The working
standard solution was prepared in 0.2 M perchloric acid containing 5 mM EDTA and 5 mM
sodium bisulfite. Five- to twenty-microliter samples were injected. The peak areas of the exter-
nal standards were used to quantify the sample peaks. At least two different dilutions were
injected for each condition analyzed, and each sample dilution was run in duplicate. The aver-
age value was determined after normalizing the concentration values with the appropriate dilu-
tion factors. For each sample used, the protein concentrations were detected using the BCA
protein assay kit (Thermo Scientific Pierce); the DA and NA concentrations were expressed in
nanomoles per gram of proteins.
Statistical Analysis
Each experiment was performed in triplicate. The data were expressed as the mean ± S.E.M.
Error propagation was used when required. Student’s t-test was used to evaluate statistically
significant differences using the GraphPad Prism software.
Results
Effect of differentiation on growth inhibition
To identify the optimal experimental conditions for differentiation, we performed a prelimi-
nary analysis with both SH-SY5Y and BE(2)-M17 cells in which growth inhibition induced by
various concentrations of each agent was tested. Starting from the values reported in previous
studies on SH-SY5Y cells [14, 16, 19], the following ranges of concentration were tested: 1.5–
150 nM for TPA, 1–50 μM for RA and 3–15 nM for staurosporine. Consistent with previous
reports for SH-SY5Y cells, we observed the most pronounced effects on growth inhibition with
15 nM TPA, 10 μMRA and 10 nM staurosporine. For BE(2)-M17 cells, the most effective
Table 1. List of primers used for qRT-PCR.
Gene Primer sequence (5'—3') Product length (bp)
GAPDH Fw: ATGAAGGGGTCATTGATGG 138
Rv: AAGGTGAAGGTCGGAGTCAA
RPII Fw-TTGGTGACGACTTGAACTGC 123
Rv-CCATCTTGTCCACCACCTCT
TH Fw: GCCCTACCAAGACCAGACGTA 89
Rv: CGTGAGGCATAGCTCCTGA
AADC Fw: GAAGCCCTGGAGAGAGACAA 121
Rv: CCTTGTTGCAGATAGGACCG
VMAT2 Fw: TGAAGAGAGAGGCAACGTCA 149
Rv: CGTCTTCCCCACAAACTCAT
DβH Fw: GCCTTCATCCTCACTGGCTA 109
Rv: TTCTCCCAGTCAGGTGTGTG
doi:10.1371/journal.pone.0136769.t001
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concentrations were 30 nM TPA, 5 μMRA and 8 nM staurosporine, which were close to the
values reported above for SH-SY5Y cells.
Then, the cells were treated with the optimized concentration of each differentiating agent.
Cell inhibition was subsequently assessed after 4 and 7 days of treatment after verifying that
none of the differentiating agents induced apoptosis or necrosis in our cell models at the exper-
imental concentrations used, as determined by cytofluorimetric analysis (S1 File). As shown in
Fig 1, all agents induced growth inhibition, albeit with different efficiencies that were depen-
dent on the type of treatment and the cell line used. In the case of SH-SY5Y, after 4 days the
inhibition levels in the presence of RA and TPA were very similar (~40%), whereas RA pro-
moted a more marked effect compared to TPA after 7 days (~70% and ~45%, respectively).
Interestingly, staurosporine induced the most pronounced inhibition. After 4 days of treat-
ment, cell proliferation was almost completely blocked, with a growth inhibition of ~80%; this
inhibition was even more evident after 7 days (~95%).
The results obtained with BE(2)-M17 cells were quite different. There was almost no effect
after 4 days of staurosporine treatment, while the growth inhibition in the presence of TPA
reached ~20%. The strongest inhibition (~40%) was obtained in the presence of RA. After 7
days, staurosporine promoted a more marked effect compared to TPA (~45% and ~20%,
respectively), although it was still low compared to the effects observed in the SH-SY5Y cells.
RA induced the strongest inhibition (~70%) after 7 days. In conclusion, staurosporine was by
far the most efficient treatment to inhibit cell growth in the SH-SY5Y cell line, while treatment
with RA induced the most effective results in the BE(2)-M17 cell line.
Morphological differentiation
Next, we explored the effect of the three differentiating agents on cell morphology. Undifferen-
tiated SH-SY5Y neuroblastoma cells displayed a characteristic morphology with rounded cell
bodies and few short processes (Fig 2). A similar morphology was also present in the BE(2)-
M17 cells, although they were smaller and the processes were less evident. After 7 days of treat-
ment the cells displayed different levels of neurite lengths and numbers depending on the
chemical used. Differentiation induced by TPA in both cell lines resulted in the formation
of fewer short processes. Instead, both RA- and staurosporine-differentiated cultures showed
a clear neuronal-like morphology with a complex network of neuritic extensions. In the
SH-SY5Y cells, these processes were longer and more numerous after treatment with stauros-
porine compared to treatment with other differentiating agents. Conversely, in the BE(2)-M17
cells a more pronounced morphological differentiation was observed upon addition of RA.
To better characterize the morphological changes and to quantify the effect of each differen-
tiating agent in terms of neurite outgrowth, cells were transfected with a cytosolic green fluo-
rescent protein that allowed neurites to be tracked at a single-cell level. Three parameters were
used for the analysis: i) the length of the longest neurite; ii) the average length of the neurites;
and iii) the number of neurites per cell. The results are summarized in Fig 3. In the SH-SY5Y
cells, TPA and RA slightly increased both the average length of the neurites and the maximum
neurite length compared with undifferentiated cells. Staurosporine was the more effective
agent in terms of both the average and maximum length. None of the differentiating agents
strongly impacted the number of neurites per cell, although there was a slight increase in the
presence of TPA. BE(2)-M17 cells showed stimulated neuritic outgrowth for each agent tested
after 7 days of treatment. The best morphological differentiation was accomplished by the
addition of RA, which not only increased neurite length but also neurite number.
Catecholaminergic Phenotype in Neuroblastoma Cell Lines
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Immunofluorescence analysis of neuronal markers
To evaluate whether differentiated cells expressed neuronal markers, we stained undifferenti-
ated and differentiated SH-SY5Y and BE(2)-M17 cells with antibodies against neuron-specific
proteins such as β-tubulin III and neurofilament. Class III β-tubulin is a microtubule element
that is expressed exclusively in neurons, while neurofilaments are types of intermediate fila-
ments present in axons. Consistent with our previous observations, RA and staurosporine
but not TPA promoted marked variations in cell morphology in both the SH-the SY5Y and BE
Fig 1. Cellular growth of undifferentiated and differentiated SH-SY5Y and BE(2)-M17 cells. All of the
examined drugs inhibited cell proliferation. In SH-SY5Y cells the effect of staurosporine was the most
pronounced, while in BE(2)-M17 cells the strongest inhibition was achieved with RA treatment. The number
of cells is shown as the mean ± S.E.M. of three experiments. Differences between differentiated and
undifferentiated cells were tested for significance using Student’s t-test. (*P<0.05, **P<0.01, ***P<0.001).
doi:10.1371/journal.pone.0136769.g001
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Fig 2. Cellular morphology of undifferentiated and differentiated SH-SY5Y and BE(2)-M17 cells after 7
days of differentiation.Representative phase contrast images showed that after 7 days of treatment,
staurosporine and RA promoted the most remarkable neurite extensions in SH-SY5Y cells and BE(2)-M17
cells, respectively. Scale bar = 100 μM.
doi:10.1371/journal.pone.0136769.g002
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(2)-M17 cell lines, inducing a neuron-like appearance (Fig 4). TPA-treated cells showed only
moderate neurite outgrowth and did not exhibit detectable neuronal-marker-positive pro-
cesses. In contrast, RA- and staurosporine-differentiated SH-SY5Y and BE(2)-M17 cells
showed a significant increase in β-tubulin III and neurofilament expression compared to undif-
ferentiated cells.
Fig 3. Neurite outgrowth in undifferentiated and differentiated SH-SY5Y and BE(2)-M17 cells after 7
days of differentiation. Staurosporine and RA promoted the most remarkable increase in neurite length in
the SH-SY5Y cells and BE(2)-M17 cells, respectively. RA treatment also increased neurite branching in BE
(2)-M17 cells. Data are expressed as the mean ± SEM of three experiments. At least 90 cells were analyzed
for each conditions. Differences between differentiated and undifferentiated cells were tested for significance
using Student’s t-test. (*P<0.05, **P<0.01, ***P<0.001).
doi:10.1371/journal.pone.0136769.g003
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Gene expression profile
To analyze the effects of differentiation on the CAergic pathway in both SH-SY5Y and BE(2)-
M17 cells, we evaluated variations in the gene expression profile before and after differentia-
tion. Specifically, we focused on the key genes involved in CA synthesis and storage: TH and
AADC are both involved in the synthesis of DA; VMAT2 rapidly sequesters DA from the cyto-
sol into synaptic vesicles; and DβH synthesizes NA from DA inside synaptic vesicles. Because
immature neurons can express markers of multiple subtypes, we also considered two choliner-
gic markers [choline acetyltransferase (ChAt) and acetylcholine esterase (AChE)] and two glu-
tamatergic markers [vesicular glutamate transporter (vGlut1) and glutamate decarboxylase
(GadD1)]. First, gene expression was analyzed using semi-quantitative methods. Specifically,
after RNA extraction, reverse transcription and PCR, the amplified cDNA was analyzed by gel
electrophoresis. As shown in Fig 5, undifferentiated wild-type SH-SY5Y cells expressed all of
the DA/NAergic markers. Nevertheless, the intensity of the bands representing TH and
VMAT2 expression were much weaker in comparison to the other markers, while the DβH-
Fig 4. Immunofluorescence staining for the neuronal markers neurofilament and β-III tubulin. The comparison was made between undifferentiated
and differentiated SH-SY5Y and BE(2)-M17 cells after 7 days of treatment. RA and staurosporine differentiation induced the formation of long processes
positive for neurofilament and β-III tubulin in both cell lines. Blue: Hoechst; Green: neurofilaments; Red: β-III tubulin; Gray: phase contrast. Scale bar = 50 μM.
doi:10.1371/journal.pone.0136769.g004
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corresponding band was the most intense. Markers of both cholinergic and glutamatergic phe-
notypes were also expressed in undifferentiated SH-SY5Y cells. Cells differentiated with both
TPA and RA did not exhibit clear differences in DAergic gene expression compared to
untreated cells, while both cholinergic and glutamatergic markers appeared slightly upregu-
lated. In contrast, upon staurosporine treatment the only appreciable difference was the upre-
gulation of VMAT2 expression. The same analysis performed on BE(2)-M17 cells revealed
interesting differences (Fig 5). First, the expression of cholinergic and glutamatergic markers
was extremely low in comparison to DAergic markers in both the undifferentiated and differ-
entiated BE(2)-M17 cells. Second, cholinergic and glutamatergic markers had very low expres-
sion levels compared with their expression levels in SH-SY5Y cells. The intensity of the bands
corresponding to TH and VMAT2 were much more intense compared to the SH-SY5Y cells.
Finally, the expression of VMAT2 appeared to be upregulated following staurosporine treat-
ment. Overall, these data indicate a more pronounced CAergic phenotype for BE(2)-M17 cells
Fig 5. Gene expression profile of DAergic, cholinergic and glutamatergic markers in SH-SY5Y and BE
(2)-M17 cells. TH, AADC, VMAT2, and DβHmRNAs were analyzed in undifferentiated cells and after 7 days
of treatment with TPA, RA and staurosporine using semi-quantitative RT-PCR.
doi:10.1371/journal.pone.0136769.g005
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compared with SH-SY5Y cells. To obtain precise quantification of the effects of differentiation
on the CAergic pathway in both SH-SY5Y and BE(2)-M17 cells, we performed qRT-PCR
experiments.
The results obtained after the addition of the differentiating agents are summarized in
Table 2 and plotted in Fig 6. In SH-SY5Y cells, the expression profiles of CA-related genes 4
days after TPA treatment were only slightly different from the undifferentiated controls, with
all genes slightly down-regulated relative to the control. This trend was more evident after 7
days of TPA treatment. We observed a trend of general down-regulation when the cells were
treated with RA, with the effects visible as early as 4 days after treatment. Analysis at 7 days
confirmed that the TH and AADC genes were the most affected, suggesting that DA synthesis
was specifically inhibited. In contrast, cells treated with staurosporine exhibited an upregula-
tion of CA-related markers at both 4 and 7 days after differentiation. Interestingly, while the
expression of the TH gene was only slightly increased, VMAT2 expression was increased by
more than 80- and 100-fold at 4 and 7 days, respectively. Expression of the DβH gene was also
considerably enhanced (~7- and ~8–fold at 4 and 7 days, respectively). Overall, the results indi-
cated that while the machinery for DA synthesis appeared to be only slightly increased by
staurosporine-induced differentiation, DA storage inside vesicles and its subsequent conver-
sion into NA was clearly favored.
The effects observed in the BE(2)-M17 cell line after differentiation were less straightfor-
ward. Generally, the expression profiles observed after 4 and 7 days of treatment were very sim-
ilar for each differentiating agent used. In the presence of TPA, the effects observed were rather
mild (with the exception of the TH gene, which was upregulated ~3-fold) and the CAergic phe-
notype did not seem to change compared to undifferentiated cells. Even in the presence of RA
the expression profiles of CA-related genes were only slightly different from the undifferenti-
ated control, with the exception of the VMAT2 gene that was down-regulated 6-10-fold. As
reported above for the SH-SY5Y cell line, staurosporine was the only agent among the differen-
tiating agents tested that increased the CAergic phenotype of the BE(2)-M17 cells. Neverthe-
less, the TH gene was also strongly upregulated (~8-fold) in addition to the VMAT2 and DβH
genes.
In conclusion, our analysis of the effects induced on the CAergic pathway by cell differentia-
tion indicated an enhancement of the NAergic phenotype both in SH-SY5Y and BE(2)-M17
cells after treatment with staurosporine. TPA and RA induced a loss of the CAergic phenotype
in SH-SY5Y cells, although this effect was less evident in the BE(2)-M17 cells.
Quantification of catecholamine levels
As reported in S2 File, we performed a Western blot analysis to assess the variations induced
by differentiation in the expression level of the proteins involved in CA synthesis and storage.
Nevertheless, because of the scanty reliability of some of the available antibodies, the results
were not straightforward. As the quantification of the intracellular levels of DA and NA could
represent a direct evaluation of the protein activity in defining the CAergic phenotype, we
then decided to quantify the intracellular amounts of DA and NA in SH-SY5Y and BE(2)-M17
cells before and after differentiation, using HPLC coupled with an electrochemical detector.
The DA and NA intracellular contents detected in the undifferentiated SH-SY5Y cells were
0.7 ± 0.1 and 1.7 ± 0.6 nmol (per gram of proteins), respectively. The DA levels were below the
level of detection after a 7-day treatment with either TPA or RA, while the concentration of
NA decreased to 0.4 ± 0.2 and 0.2 ± 0.1 nmol/g, respectively. This result is in agreement with
our gene expression analysis and indicates a loss of the CAergic phenotype. Conversely, follow-
ing the 7-day treatment with staurosporine the DA and NA levels were augmented to 2.4 ± 0.6
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and 11 ± 3 nmol/g, respectively, indicating that differentiation promoted a more marked NAer-
gic phenotype. The amounts of DA and NA detected in undifferentiated BE(2)-M17 cells were
9.2 ± 1.2 and 5.4 ± 1.7 nmol/g, respectively. Treatment with TPA for 7 days increased the levels
of both DA and NA (11.3 ± 1.9 and 17.7 ± 3.0 nmol/g, respectively), which was in line with
the modest upregulation of the TH and DβH genes observed through qRT-PCR. Moreover, in
Table 2. Gene expression profile of the primary catecholaminergic markers after differentiation.
SH-SY5Y BE(2)-M17
TPA TH AADC VMAT2 DβH TH AADC VMAT2 DβH
4 days 0.75±0.02 0.68±0.08 0.74±0.04 0.73±0.05 3.0 ±0.2 1.30±0.10 0.67±0.08 1.93±0.19
7 days 0.18±0.06 0.33±0.04 0.38±0.03 0.25±0.03 2.6±0.2 1.19±0.10 0.75±0.06 1.31±0.15
RA TH AADC VMAT2 DβH TH AADC VMAT2 DβH
4 days 0.14±0.03 0.40±0.03 0.30±0.01 0.79±0.05 0.93±0.06 1.34±0.08 0.14±0.01 0.58±0.05
7 days 0.05±0.02 0.10±0.01 0.34±0.02 0.40±0.04 0.85±0.05 1.48±0.12 0.11±0.01 0.87±0.07
Stauro TH AADC VMAT2 DβH TH AADC VMAT2 DβH
4 days 1.42±0.03 3.3±0.2 83±3 7.3±0.4 7.9±1.5 1.49±0.09 19.1±1.5 21±2
7 days 1.12±0.03 2.7±0.3 105±2 7.9±1.0 8.2±0.6 1.54±0.11 36±2 16.8±1.1
doi:10.1371/journal.pone.0136769.t002
Fig 6. Gene expression profile of CAergic markers in differentiated SH-SY5Y and BE(2)-M17 cells. After 4 and 7 days of differentiation with TPA, RA
and staurosporine, TH, AADC, VMAT2 and DβHmRNA levels were compared with their corresponding levels in undifferentiated cells using qRT-PCR.
Expression was displayed on a Log2 scale. Positive and negative values indicated up and downregulation of the genes with respect to control cells
(undifferentiated cells), respectively. For each gene, differences between differentiated and undifferentiated cells were tested for significance using Student’s
t-test. (*P<0.05, **P<0.01, ***P<0.001).
doi:10.1371/journal.pone.0136769.g006
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agreement with our gene expression analysis the CA content was not significantly modified by
RA treatment, while the presence of staurosporine induced a strong increase in both the DA
and NA concentrations. These results are summarized in Table 3.
Discussion
Cellular models are instrumental for in vitro or ex vivo studies to analyze the cellular pathways
that govern physiological or pathological processes or to evaluate the cell toxicity or protection
induced by different compounds, including potential drugs. While human induced pluripotent
stem cells are emerging as the most suitable model, they are still mostly inaccessible for many
research groups. As a consequence, it is germane to define robust criteria to choose the most
suitable model from the several cellular models available to address the scientific question
posed by the object of investigation. To provide one of these criteria, here we investigated the
CAergic pathway of two human neuroblastoma cell lines: SH-SY5Y and BE(2)-M17. The first
cell line has been largely studied and used in the field of neuroscience; therefore, it was chosen
in this study for comparison; the second cell line has been poorly characterized to date and has
emerged as a new experimental paradigm with a different CAergic phenotype.
Although undifferentiated SH-SY5Y and BE(2)-M17 cells are used in some circumstances,
their differentiation towards a more neuronal phenotype is often preferred. For example,
because undifferentiated cells are continuously dividing, their replication during the course of
the experiment makes it difficult to unravel the extent to which neuroprotective or neurotoxic
molecules influence the proliferation or cell degeneration rate, respectively [24]. For this rea-
son, in the first part of this study we focused on the effects induced by three differentiating
agents (RA, TPA and staurosporine) on growth inhibition, cell morphology and the expression
of neuronal markers. The mechanism whereby RA regulates neurite outgrowth and growth
inhibition includes the regulation of the transcription of neurotrophin receptors [25], the
involvement of the Wnt signaling pathways [26] and the participation of type II protein kinase
A [27]. The differentiating effects of TPA and staurosporine are primarily mediated by protein
kinase C (PKC) isoforms. Nevertheless, while TPA is a PKC activator, staurosporine is a potent
PKC inhibitor, suggesting distinct roles for different PKC isoforms during neuronal differentia-
tion [28–31]. Our results indicated that all of the analyzed chemicals affected cell proliferation.
Nevertheless, staurosporine was the most efficient treatment at inhibiting cell growth in the
SH-SY5Y cell line, while treatment with RA was the most effective with the BE(2)-M17 cell
line. Moreover, while TPA resulted in the formation of few and short processes in each cell
line, both RA and staurosporine promoted a complex network of neuritic extensions. Finally,
our immunofluorescence analysis demonstrated that SH-SY5Y and BE(2)-M17 cells expressed
Table 3. Cathecolamine contents detected in SH-SY5Y and BE(2)-M17 cell lines before and after differ-
entiation for 7 days.
DA NA
SH-SY5Y undifferentiated 0.7±0.1 1.7±0.6
SH-SY5Y with TPA nd 0.4±0.2
SH-SY5Y with retinoic acid nd 0.2±0.1
SH-SY5Y with staurosporine 2.4±0.6 11±3
BE(2)-M17 undifferentiated 9.2±1.2 5.4±1.7
BE(2)-M17 with TPA 11.3±1.9 18±3
BE(2)-M17 with retinoic acid 9.7±1.5 7.5±1.5
BE(2)-M17 with staurorine 40±12 45±14
doi:10.1371/journal.pone.0136769.t003
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both β-III-tubulin and neurofilament, which are two markers of mature neurons, following
RA- and staurosporine-induced differentiation.
Having confirmed the capability of each cell line to differentiate and adopt a neuron-like
phenotype, we investigated and compared the CAergic pathways of these cells before and
after differentiation using expression profile analysis of the major genes involved in CA
metabolism (i.e., TH, AADC, VMAT2 and DβH). Our results in SH-SY5Y cells indicated that
both RA and TPA promoted the loss of the CAergic phenotype. In contrast, staurosporine
treatment resulted in upregulation of all CA-related genes (particularly VMAT2 and DβH).
Conversely, the effects of TPA and RA on BE(2)-M17 cells were less evident, although staur-
osporine induced the upregulation of the genes involved in CA metabolism. The next step
would have been a Western blot analysis to detect the translation products of the analyzed
genes, but the scanty reliability of some of the available antibodies hindered trustworthy
quantification [32, 33]. Therefore, we reasoned that quantification of the intracellular levels
of DA and NA could represent a direct evaluation of the protein activity in defining the CAer-
gic phenotype. Our data showed that both DA and NA accumulated in the undifferentiated
SH-SY5Y cells, with the level of NA higher than DA. Consistent with the increased expression
of the DβH gene, we observed a large increase in NA content relative to the control cells upon
staurosporine treatment. In conclusion, the SH-SY5Y cells exhibit a more marked NAergic
phenotype that was further enhanced following staurosporine-induced differentiation. The
results obtained with the BE(2)-M17 cells were very interesting. First, the CA amounts
detected in the undifferentiated cells were considerably higher than those observed for
SH-SY5Y cells, indicating a more pronounced CAergic phenotype. Despite the presence of
DβH, which should transform the newly synthesized DA into NA, DA was not only detectable
but its concentration was even higher than the NA concentration. It is worth mentioning that
high levels of DA were detected even though high DβH activity was measured also in the
SK-N-BE(2) cells from which the BE(2)-M17 cells were subcloned [34]; this observation was
consistent with our results. Furthermore, similar to the results obtained with the SH-SY5Y
cells, we observed a large increase in both the DA and NA contents relative to the control cells
following treatment with staurosporine.
In conclusion, our results emphasize that the two cell lines tested possess similar abilities to
differentiate and acquire a neuron-like morphology. The most evident effects in the SH-SY5Y
cells were observed in the presence of staurosporine, while in the BE(2)-M17 cells RA induced
the strongest effects. Interestingly, relevant differences between the two cell lines were observed
concerning the CAergic pathway. The basal expression of both DA and NA in undifferentiated
cells was much more elevated in BE(2)-M17 cells, indicating that this cell line possesses a more
pronounced CAergic phenotype compared with SH-SY5Y cells. Moreover, BE(2)-M17 cells
have a more prominent DAergic phenotype, which makes the use of this cell line more suitable
for studies focused on Parkinson’s disease, where the presence of DA appears to be an impor-
tant requirement for a cell model. The use of these cells (both undifferentiated or after
differentiation) should be avoided when the CAergic phenotype is not required (e.g., studies
concerning Alzheimer’s disease). In this last example, the use of SY-SY5Y cells after differentia-
tion using either RA or TPA appears to be much more appropriate.
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